Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Xu

Showing results (1131-1140 of 1,148) with videos related to

Pageof 115
Sort By:
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|February 9, 2021
[Expert consensus on the treatment of oral and maxillofacial space infections]Y P Li, B Shi, J R Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2020
Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trialB Xu, T Sun, Q Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 15, 2022
[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component]Z J Lin, J Zha, S H Yi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2024
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trialG N Hortobagyi, A Lacko, J Sohn, et al.
Molecular Psychiatry|June 14, 2017
The Arf6 activator Efa6/PSD3 confers regional specificity and modulates ethanol consumption in Drosophila and humansD A Gonzalez, T Jia, J H Pinzón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Journal of Neurotrauma|November 9, 2020
High-Sensitivity C-Reactive Protein is a Prognostic Biomarker of Six-Month Disability after Traumatic Brain Injury: Results from the TRACK-TBI StudyLinda B Xu, John K Yue, Frederick Korley, et al.
Nature Materials|November 9, 2021
Photocurrent-driven transient symmetry breaking in the Weyl semimetal TaAsN Sirica, P P Orth, M S Scheurer, et al.
Journal of Biotechnology|February 13, 2001
Physiological responses to mixing in large scale bioreactorsS O Enfors, M Jahic, A Rozkov, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 6, 2021
[Prognosis and related risk factors of acute respiratory distress syndrome in elder patients]X Huang, D W Wu, H N Lu, et al.
Pageof 115

Showing results (1131-1140 of 1,148) with videos related to

Sort By:
Pageof 115
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|February 9, 2021
[Expert consensus on the treatment of oral and maxillofacial space infections]Y P Li, B Shi, J R Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2020
Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trialB Xu, T Sun, Q Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 15, 2022
[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component]Z J Lin, J Zha, S H Yi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2024
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trialG N Hortobagyi, A Lacko, J Sohn, et al.
Molecular Psychiatry|June 14, 2017
The Arf6 activator Efa6/PSD3 confers regional specificity and modulates ethanol consumption in Drosophila and humansD A Gonzalez, T Jia, J H Pinzón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Journal of Neurotrauma|November 9, 2020
High-Sensitivity C-Reactive Protein is a Prognostic Biomarker of Six-Month Disability after Traumatic Brain Injury: Results from the TRACK-TBI StudyLinda B Xu, John K Yue, Frederick Korley, et al.
Nature Materials|November 9, 2021
Photocurrent-driven transient symmetry breaking in the Weyl semimetal TaAsN Sirica, P P Orth, M S Scheurer, et al.
Journal of Biotechnology|February 13, 2001
Physiological responses to mixing in large scale bioreactorsS O Enfors, M Jahic, A Rozkov, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 6, 2021
[Prognosis and related risk factors of acute respiratory distress syndrome in elder patients]X Huang, D W Wu, H N Lu, et al.
Pageof 115